Cargando…
Efficacy of central nervous system prophylaxis with stand-alone intrathecal chemotherapy in diffuse large B-cell lymphoma patients treated with anthracycline-based chemotherapy in the rituximab era: a systematic review
Central nervous system (CNS) relapse of diffuse large B-cell lymphoma remains uncommon but catastrophic. The benefit of standalone intrathecal prophylaxis in reducing CNS recurrence is unclear and remains controversial. No systematic review analysing the evidence for stand-alone intrathecal prophyla...
Autores principales: | Eyre, Toby A., Djebbari, Faouzi, Kirkwood, Amy A., Collins, Graham P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327624/ https://www.ncbi.nlm.nih.gov/pubmed/31488560 http://dx.doi.org/10.3324/haematol.2019.229948 |
Ejemplares similares
-
Treatment outcome in children with central nervous system-positive Burkitt lymphoma using only intrathecal and systemic chemotherapy combined with rituximab
por: Huang, Shuang, et al.
Publicado: (2021) -
Anthracycline Chemotherapy and Cardiotoxicity
por: McGowan, John V, et al.
Publicado: (2017) -
Advances in anthracycline chemotherapy : epirubicin /
Publicado: (1984) -
Clinicopathological analysis of primary adrenal diffuse large B-cell lymphoma: effectiveness of rituximab-containing chemotherapy including central nervous system prophylaxis
por: Ichikawa, Satoshi, et al.
Publicado: (2013) -
Intrathecal Chemotherapy: Selection of Cytostatic Agents
por: Hayakawa, T., et al.
Publicado: (1970)